Vimarsana
Biggest News Aggregation in the World

Toby Cousens News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Toby Cousens. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Toby Cousens Today - Breaking & Trending Today

Pfizer's first acute migraine treatment recommended by NICE - Vimarsana News

Pfizer's first acute migraine treatment recommended by NICE

The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care Excellence (NICE).

Thousands of Brits battling migraines set to get new pain-busting pill - Vimarsana News

Thousands of Brits battling migraines set to get new pain-busting pill

The drug, sold by Covid jab maker Pfizer has previously been endorsed by reality star and migraine sufferer Khloe Kardashian and is now set to benefit 13,000 Brits living with acute migraines.

Migraine breakthrough for millions of sufferers as NHS to offer revolutionary treatment - Vimarsana News

Migraine breakthrough for millions of sufferers as NHS to offer revolutionary treatment

The regulator said its approval of groundbreaking Rimegepant marks a 'step-change in treatment' for the 'invisible disability that affects all aspects of life'

Migraine sufferers get relief after new pill approved for NHS - Vimarsana News

Migraine sufferers get relief after new pill approved for NHS

{"desktop":[{"injectionEnabled":false,"componentType":"gpt","targeting":{"index":-1,"hivis":"n"},"referenceNode":"header","hideOnSensitiveArticle":true,"hideOnFirstPageView":true,"relativePos":"after","name":"div-gpt-ad-oop-slot","isOOP":true,"type":"outOfPage"},{"componentType":"gpt","targeting":{"index":-2,"hivis":"n"},"referenceNode":&...

Rimegepant: New Pill To Combat Migraines Approved For NHS - Vimarsana News

Rimegepant: New Pill To Combat Migraines Approved For NHS

Rimegepant could soon be an option on the NHS for 145,000 patients where previous treatments have failed.